Pulmonary embolism causes: Difference between revisions
Ochuko Ajari (talk | contribs) |
Ochuko Ajari (talk | contribs) |
||
Line 29: | Line 29: | ||
{|style="width:80%; height:100px" border="1" | {|style="width:80%; height:100px" border="1" | ||
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular''' | |style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular''' | ||
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | | |style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Antithrombin III deficiency]], [[deep vein thrombosis]], [[dyslipidemia]], [[embolism]], [[fat]], [[heart failure]], [[hypercholesterolemia]], [[hypertension]], [[May-Thurner syndrome]], [[Meadows syndrome]], [[Paget-Schroetter disease]], [[venous thrombosis|pelvic vein thrombosis]], [[plasminogen|plasminogen deficiency]], [[thromboembolism]], [[thrombosis]] | ||
|- | |- | ||
|bgcolor="LightSteelBlue"| '''Chemical/Poisoning''' | |bgcolor="LightSteelBlue"| '''Chemical/Poisoning''' | ||
Line 40: | Line 40: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Dermatologic''' | | '''Dermatologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Behcet's disease]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Bevacizumab]], [[glucocorticoids]], [[heparin-induced thrombocytopenia]], [[hormone replacement therapy]], [[lenalidomide]], [[neuroleptic malignant syndrome]], [[oral contraceptives]], [[tamoxifen]], [[testosterone]], [[thalidomide]], [[transdermal contraceptive]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 52: | Line 52: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Polycystic ovary syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 60: | Line 60: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Gastroenterologic''' | | '''Gastroenterologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Colorectal cancer]], [[inflammatory bowel disease]], [[liver disease]], [[Paget-Schroetter disease]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Paroxysmal nocturnal hemoglobinuria]], [[protein C deficiency]], [[protein S deficiency]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Antiphospholipid syndrome]], [[antithrombin III deficiency]], [[deep vein thrombosis]], [[embolism]], [[essential thrombocythemia]], [[essential thrombocytosis]], [[factor V Leiden mutation]], [[factor XII|factor XII deficiency]], [[familial dysfibrinogenemia]], [[heparin cofactor II|heparin cofactor II deficiency]], [[heparin-induced thrombocytopenia]], [[hyperviscosity]], [[paroxysmal nocturnal hemoglobinuria]], [[venous thrombosis|pelvic vein thrombosis]], [[plasminogen|plasminogen deficiency]], [[polycythemia vera]], [[protein C deficiency]], [[protein S deficiency]], [[thromboembolism]], [[thrombosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Iatrogenic''' | | '''Iatrogenic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Cancer surgery]], [[neurosurgery]], [[orthopedic surgery]], [[central venous catheter|presence of central venous catheter]], [[vascular surgery]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Infection]], [[tuberculosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Musculoskeletal/Orthopedic''' | | '''Musculoskeletal/Orthopedic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Bone fractures]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Corticobasal degeneration]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional/Metabolic''' | | '''Nutritional/Metabolic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Dyslipidemia]], [[hypercholesterolemia]], [[hyperhomocysteinemia]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Amniotic fluid]], [[antiphospholipid syndrome]], [[hormone replacement therapy]], [[Meadows syndrome]], [[oral contraceptives]], [[ovarian hyperstimulation syndrome]], [[polycystic ovary syndrome]], [[pregnancy]], [[transdermal contraceptive]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Oncologic''' | | '''Oncologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Cancer]], [[colorectal cancer]], [[lung cancer]], [[malignancy]], [[pancreatic cancer]], [[polycythemia vera]], [[prostate cancer]], [[renal cell carcinoma]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 108: | Line 108: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Psychiatric''' | | '''Psychiatric''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Corticobasal degeneration]], [[neuroleptic malignant syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Pulmonary''' | | '''Pulmonary''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Asthma]], [[lung cancer]], [[thrombosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Renal/Electrolyte''' | | '''Renal/Electrolyte''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Chronic renal disease]], [[nephrotic syndrome]], [[renal cell carcinoma]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Rheumatology/Immunology/Allergy''' | | '''Rheumatology/Immunology/Allergy''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Antiphospholipid syndrome]], [[Behcet's disease]], [[Hughes-Stovin syndrome]], [[prothrombin gene mutation G20210A]], [[rheumatoid arthritis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 128: | Line 128: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Trauma''' | | '''Trauma''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Injury]], [[intravenous drug use]], [[surgery]], [[trauma]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Urologic''' | | '''Urologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Prostate cancer]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Miscellaneous''' | | '''Miscellaneous''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Cancer surgery]], [[immobility|immobilization]], [[neurosurgery]], [[orthopedic surgery]], [[renal transplantation]], [[vascular surgery]] | ||
|- | |- | ||
|} | |} | ||
===Causes in Alphabetical Order=== | ===Causes in Alphabetical Order=== |
Revision as of 11:11, 7 September 2014
Resident Survival Guide |
Pulmonary Embolism Microchapters |
Diagnosis |
---|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
Treatment |
Follow-Up |
Special Scenario |
Trials |
Case Studies |
Pulmonary embolism causes On the Web |
Risk calculators and risk factors for Pulmonary embolism causes |
Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2] Ogheneochuko Ajari, MB.BS, MS [3]
Overview
Pulmonary embolism (PE) is the acute obstruction of the pulmonary artery or one of its branches by a thrombus, air, tumor, or fat. Most often, PE is due to a venous thrombus which has been dislodged from its site of formation in the deep veins of the lower extremities, a process referred to as venous thromboembolism.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Pulmonary embolism is a life-threatening condition and must be treated as such irrespective of the underlying cause.
Common Causes
- The most common cause of PE is a venous thrombus which has been dislodged from its site of formation in the deep veins of the lower extremities.
- Non-thrombotic causes of PE are: